Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftment.

@article{Publicover2013UseOA,
  title={Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftment.},
  author={Amy Publicover and Deborah South Richardson and Andrew Davies and Kate Hill and Carol Hurlock and David Hutchins and Matthew W. Jenner and Peter W M Johnson and Jane Lamb and Harriet Launders and Nikki McKeag and Joan Newman and Kim Orchard},
  journal={British journal of haematology},
  year={2013},
  volume={162 1},
  pages={107-11}
}
Peripheral blood haematopoietic progenitor cell mobilization has become a standard procedure prior to autologous stem cell transplantation. Biosimilar granulocyte colony-stimulating factors (GCSF) have recently been awarded European Union (EU) licences for stem cell mobilization but data for their use in this context remain limited. The biosimilar GCSF, Ratiograstim(®) (Ratiopharm, Ulm, Germany) was granted an EU licence in September 2008 and incorporated into clinical practice in the Wessex… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Use of biosimilar granulocyte colony stimulating factor ( GCSF ) for peripheral blood progenitor cell mobilisation prior to autologous stem cell transplant : a single centre experience

  • A. Publicover, D. S. Richardson, +5 authors K. Orchard
  • Bone Marrow Transplantation
  • 2010
Highly Influential
3 Excerpts

Use of biosimilar granulocyte colony stimulating factor (GCSF) for peripheral blood progenitor cell mobilisation

  • A. Publicover, D. S. Richardson, +5 authors K. Orchard
  • 2010
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…